Levact: new blood cancer drug

Levact: a new chemotherapy agent
Levact: a new chemotherapy agent

Bendamustine is an alkylating antitumour agent with unique activity.1 It is licenced for use:

  • in the first-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) when fludarabine combination chemotherapy is not appropriate.
  • as monotherapy for indolent non-Hodgkin’s lymphoma that has progressed during or within 6 months of rituximab treatment.
  • in combination with prednisone for multiple myeloma (Durie-Salmon stage II with progress or stage III) in patients >65 years who are not eligible for autologous stem cell transplantation, thalidomide or bortezomib.

The drug’s antineoplastic and cytocidal effects are based on the cross-linking of DNA single and double strands by alkylation, which results in impaired DNA synthesis and repair.

Clinical studies have shown that there is no complete cross-resistance of bendamustine with anthracyclines, alkylating agents or rituximab, however, the number of assessed patients was small.1

View Levact drug record

REFERENCES

  1. Levact Summary of Product Characteristics, August 2010.

Further information: Napp


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases